Eli Lilly and CompanyLLY
NYSE•Healthcare•Drug Manufacturers - General
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $72.25B, growing 47.4% year-over-year. TTM net income stood at $25.28B (127.6% growth). Quarterly EBITDA was $9.42B and operating income was $8.91B. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze LLY growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters